Last Updated : Thursday, January 16, 2020 12:07:41

Tag Archives: ANDA

STRIDES PHARMA gets USFDA nod to market nasal treatment drug

BANGALORE | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Bangalore headquartered Strides Pharma Science Ltd said of having USFDA (US Food and Drugs Administration) nod to market nasal treatment drug – Loratadine OTC Softgel Capsules in 10 mg dosage value. The press-release titled, “Strides receives USFDA approval for Loratadine OTC Softgel Capsules”, enclosed with

ALEMBIC PHARMA gets USFDA nod to market anti-diabetic drug

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara headquartered Indian Pharmaceutical products manufacturing major – Alembic Pharmaceuticals Ltd said of having got tentative approval for marketing anti-diabetic drug – Empagliflozin Tablets in dosages of 10 mg (milligram) and 25 mg, primely aimed to substitute

ALEMBIC PHARMA gets USFDA nod to market anti-spasm drug

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Indian pharmaceutical major – Alembic Pharmaceuticals Ltd said of having got approval to market anti-spasm (muscle contraction) drug. The release titled, “Alembic Pharmaceuticals announces USFDA Final Approval for Tizanidine Hydrochloride Capsules, 2 mg, 4

ALEMBIC PHARMA gets USFDA nod to market depressive disorder treatment

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered India pharmaceutical major – Alembic Pharmaceuticals receives USFDA Final Approval for drug Vilazodone Hydrochloride Tablets in 10 mg. 20 mg, and 40 mg dosage, which is used to treat depressive disorder and had a

Dr REDDY’s gets USFDA nod to market medicine to treat tumour

PRINCETON (NEW JERSEY – US) HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Hyderabad headquartered pharmaceutical company Dr Reddy’s Laboratories Ltd said of having got USFDA (US Food & Drugs Administration) nod to market medicine to treat tumour for bone-marrow and cancer and has

STRIDE PHARMA gets USFDA nod to market pain-killer medicine

BANGALORE | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Bangalore headquartered pharmaceuticals company Strides Pharma Sciences Ltd said its Singapore based step-down subsidiary company Strides Pharma Global Pte. Ltd., Singapore of having got USFDA (US Food and Drugs Administration) approval to market pain-killer medicine –

ALEOR DERMA gets USFDA nod to market medicine to treat knee pain

VADODARA (BARODA) | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered pharmaceutical products manufacturing company Alembic Pharmaceuticals Ltd said of its joint-venture company Aleor Dermaceuticals having got USFDA nod to market medicine to treat knee pain. In a press-release as submitted by the company to the

ALEMBIC PHARMA gets USFDA nod to sell medicine to cure Prostate Enlargement

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Alembic Pharmaceuticals Ltd said of having got nod to market medicines to treat prostate enlargement disease. In a press-release as submitted by the company to the Indian Bourses, titled – “Alembic Pharmaceuticals receives

GLENMARK PHARMA gets USFDA nod to market medicine to treat obesity

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Glenmark Pharmaceuticals Ltd said of having received USFDA (US Food and Drugs Administration) nod to market medicine to treat obesity and overweight related disorders. In a company press-release as submitted to the Indian Bourses, titled – “Glenmark

ALEMBIC PHARMA gets USFDA nod to sell tablets to treat iron levels in blood

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Vaoddara headquartered pharmaceutical products manufacturing company Alembic Pharmaceuticals Ltd said of having got nod to market medicine to treat iron levels in blood, especially to treat chronic iron overload due to blood transfusions in patients of

GLENMARK PHARMA gets USFDA nod to market skin & pimple care treatment

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press-release submitted to the Indian Stock Exchanges, Mumbai headquartered pharma company Glenmark Pharmaceuticals Ltd said of having got nod from USFDA (US Food & Drugs Administration) to market skin & pimple care treatment. The press-release as submitted by the company to the Indian Bourses – titled, “Glenmark

USFDA issues warning, initiates official action against LUPIN’s Mandideep unit

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Indian Pharma major Lupin Ltd said of US FDA (Food & Drugs Administration) having issued warning letter and initiated official action against Mandideep facility of the company. The company update as submitted to the Indian Bourses read

UNICHEM LABS gets USFDA nod to market URINARY disorder treatment

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Mumbai headquartered Unichem Laboratories Ltd said of having got nod from US FDA (Food & Drugs Administration) to market drug to treat urinary disorders. The company statement submitted to the Indian Bourses read that, Unichem Laboratories Limited is pleased to

STRIDES PHARMA acquires USFDA approved manufacturing facility in the US

BENGALURU | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Bengaluru & Mumbai headquartered Indian Pharma Major, Strides Pharma Science Ltd said of having acquired US FDA (Food & Drugs Admininstration) approved manufacturing facility at Riviera Beach (Florida) in The United State of America. The press-release as

GLENMARK gets USFDA nod to market medicine to treat BREAST-CANCER

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update filing sumitted to the Indian Stock Exchanges, Mumbai headquartered Indian Pharma company Glenmark Pharmaceuticals Ltd said of having got approval from US FDA (Food & Drugs Administration) to market injections to treat breast-cancer. The press-communication submitted by the company to the Indian Bourses titled –

Cadila gets USFDA nod to market blood-pressure, heart disease treatment drug

AHMEDABAD | MUMBAI | RAJKOT – In a press-release submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharma major Cadila Healthcare Ltd (Dr. Pankaj Patel led Zydus Cadila Group) said of having got approval from US FDA (Food & Drugs Administration) to market tablets to treat blood-pressure and heart disease. The press-statement, as addressed by

Do NOT follow this link or you will be banned from the site!